We are live on ! Find out more
AIM

AIM ImmunoTech
AIM

22 hedge funds and large institutions have $4.64M invested in AIM ImmunoTech in 2020 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

218% more capital invested

Capital invested by funds: $1.46M → $4.64M (+$3.18M)

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

20% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 10

10% more funds holding

Funds holding: 20 → 22 (+2)

Holders
22
Holders Change
+2
Holders Change %
+10%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
4
Reduced
2
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$1.13M
2
Morgan Stanley
Morgan Stanley
New York
+$1.11M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$686K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$376K
5
Northern Trust
Northern Trust
Illinois
+$140K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$498K
2
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$327K
3
Jane Street
Jane Street
New York
-$72K
4
Osaic Holdings
Osaic Holdings
Arizona
-$56.6K
5
Goldman Sachs
Goldman Sachs
New York
-$38K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$1.18M +$1.11M +4,586 +2,520%
BlackRock
2
BlackRock
New York
$1.18M +$1.13M +4,656 +4,434%
Vanguard Group
3
Vanguard Group
Pennsylvania
$915K +$686K +2,825 +326%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$383K +$376K +1,549 New
VF
5
Virtu Financial
New York
$165K +$162K +666 New
Northern Trust
6
Northern Trust
Illinois
$143K +$140K +576 New
SWM
7
SeaCrest Wealth Management
New York
$115K +$113K +466 New
Wells Fargo
8
Wells Fargo
California
$91K +$87.4K +360 +3,273%
HighTower Advisors
9
HighTower Advisors
Illinois
$75K +$72.8K +300 New
SAMH
10
Shanda Asset Management Holdings
British Virgin Islands
$72K +$70.4K +290 New
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
$63K +$61.4K +253 New
Charles Schwab
12
Charles Schwab
California
$51K +$49.3K +203 New
CS
13
Credit Suisse
Switzerland
$44K +$43K +177 New
Bank of America
14
Bank of America
North Carolina
$39K -$8.01K -33 -17%
MFG
15
Magnus Financial Group
New York
$35K +$34K +140 New
SLG
16
Stanley-Laman Group
Pennsylvania
$32K +$31.6K +130 New
TCM
17
Traynor Capital Management
Pennsylvania
$29K – – –
SFI
18
Susquehanna Fundamental Investments
Pennsylvania
$29K +$28.2K +116 New
Osaic Holdings
19
Osaic Holdings
Arizona
$1K -$56.6K -233 -98%
APA
20
American Portfolios Advisors
New York
$565 – – –
Millennium Management
21
Millennium Management
New York
– -$498K -1,946 Closed
Hudson Bay Capital Management
22
Hudson Bay Capital Management
Connecticut
– -$327K -1,279 Closed
Jane Street
23
Jane Street
New York
– -$72K -281 Closed
Goldman Sachs
24
Goldman Sachs
New York
– -$38K -148 Closed
ASN
25
Advisory Services Network
Georgia
– -$32K -125 Closed
1
2

AIM Hedge Fund Activity: Q2 2020 in Review

22 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q2 2020, worth a combined $4.64M — up 218% from $1.46M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new AIM positions and 10 closed out — a net gain of 2 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was BlackRock, adding an estimated $1.13M. The largest seller was Millennium Management, exiting entirely with an estimated $498K sold.

  • 22 institutional investors held AIM ImmunoTech (AIM) as of Q2 2020, up from 20 in Q1 2020.
  • Funds reported $4.64M of AIM ImmunoTech stock for Q2 2020, up 218% quarter-over-quarter.
  • 12 funds opened new AIM ImmunoTech positions in Q2 2020 and 10 closed out, a net change of +2 holders.
  • The largest AIM ImmunoTech buyer in Q2 2020 was BlackRock, an estimated $1.13M added.
  • The largest AIM ImmunoTech seller in Q2 2020 was Millennium Management, an estimated $498K sold.

Based on aggregated 13F filings for Q2 2020.